Cantor Fitzgerald upgraded Gilead (GILD) to Overweight from Neutral with a price target of $125, up from $100, as the analyst took over coverage of the stock.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Gilead reports ASCENT-04/KEYNOTE-D19 study met primary endpoint
- Gilead ASCENT-04 data a ‘welcome surprise,’ says Oppenheimer
- Options Volatility and Implied Earnings Moves This Week, April 21 – April 25, 2025
- Gilead Sciences: Strong Financial Outlook and Strategic Positioning Justify Buy Rating
- JPMorgan CEO Jamie Dimon Warns U.S. Has No “Divine Right to Success” Under Tariffs